Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

BACKGROUND: Patients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections. Immunomodulators (e.g., anti-tumor necrosis factors, anti-interleukin [anti-IL]-23, anti-IL-17, Janus kinase inhibitors) increase risk of infections....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Clin Dermatol
Autors principals: Eichenfield, Lawrence F., Bieber, Thomas, Beck, Lisa A., Simpson, Eric L., Thaçi, Diamant, de Bruin-Weller, Marjolein, Deleuran, Mette, Silverberg, Jonathan I., Ferrandiz, Carlos, Fölster-Holst, Regina, Chen, Zhen, Graham, Neil M. H., Pirozzi, Gianluca, Akinlade, Bolanle, Yancopoulos, George D., Ardeleanu, Marius
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533236/
https://ncbi.nlm.nih.gov/pubmed/31066001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00445-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars